FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to chemical-pharmaceutical industry, namely to creation of pharmaceutical composition in form of hard peroral drug form for treatment of gastrointestinal tract diseases. Pharmaceutical composition contains the following ingredients: trimebutin maleate, lactose, colloidal silicon dioxide, talc, corn starch, magnesium stearate.
EFFECT: obtained pharmaceutical composition ensures high clinical effect.
5 cl, 2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| RETARD TABLETS OF TRIMEBUTINE | 2013 |
|
RU2536254C1 |
| PHARMACEUTICAL COMPOSITION OF PROLONGED ACTION FOR CORRECTION OF PSYCHOSOMATIC MANIFESTATIONS | 2009 |
|
RU2424807C2 |
| AGENT FOR TREATING FUNCTIONAL GASTROINTESTINAL DISEASES | 2020 |
|
RU2740750C1 |
| PHARMACEUTICAL COMPOSITION FOR CORRECTION OF PSYCHOSOMATIC MANIFESTATIONS | 2009 |
|
RU2384336C1 |
| PHARMACEUTICAL COMPOSITION OF PROLONGED ACTION BASED ON CLOZAPINE OF PERORAL INTRODUCTION | 2009 |
|
RU2414903C1 |
| METHOD FOR PRODUCTION OF CLOZAPINE PHARMACEUTICAL COMPOSITION IN FORM OF TABLETS AND PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2441651C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING MENTAL, BEHAVIOUR AND COGNITIVE DISORDERS | 2012 |
|
RU2488388C1 |
| DRUG PREPARATION IN FORM OF ORALLY DISPERSIBLE TABLET AND METHOD FOR MAKING DRUG PREPARATION | 2012 |
|
RU2503447C1 |
| COMBINATION OF MIRTAZAPINE AND TIZANIDINE FOR USE IN PAIN DISORDERS | 2019 |
|
RU2736713C1 |
| SUSTAINED RELEASE CILOSTASOL DOSAGE FORM | 2018 |
|
RU2686066C1 |
